SFB/TR 241/2, TP C04 A phase II multi-center clinical trial to study the efficacy and in vivo trafficking of autologous adoptively transferred ex vivo expanded regulatory T cells in patients with ulcerative colitis

Reallocation / Closing: 01.07.2022

Friedrich-Alexander-Universität Erlangen-Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg Zentralbereich
DFG-Sonderforschungsbereiche/ Transregios/Transferbereiche
Sonderforschungsbereich/Transregio 241/2: Immune-Epithelial Communication in Inflammatory Bowel Diseases (IEC in IBD)

Address

Ulmenweg 18
91054 Erlangen